Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2350 of 3546 entries
View as:

To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers

Phase: N/A Priority: Normal
NCT ID: NCT01738867 Org: User:
Start: 12/12/12 End: 05/27/14 Due: 05/27/15

Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months

Phase: N/A Priority: Normal
NCT ID: NCT00197236 Org: User:
Start: 11/11/03 End: 12/03/07 Due: 12/03/08

A Study to Compare the Effect on Heart Rhythm of 3 Days of GSK189075, Placebo, or Moxifloxacin in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00532610 Org: User:
Start: 09/30/07 End: 02/29/08 Due: 02/28/09

Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT02832362 Org: User:
Start: 06/11/16 End: 07/18/16 Due: 07/18/17

A Phase IIA FF/VI Study to Measure FeNO in Asthmatic Patients.

Phase: N/A Priority: Normal
NCT ID: NCT02712047 Org: User:
Start: 04/29/16 End: 02/21/17 Due: 02/21/18

Effect of Mepolizumab in Severe Bilateral Nasal Polyps

Phase: N/A Priority: Normal
NCT ID: NCT03085797 Org: User:
Start: 05/25/17 End: 12/11/19 Due: 12/11/20

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT03739710 Org: User:
Start: 01/24/19 End: 05/02/24 Due: 05/02/25

A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 and FF in Japanese Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01244984 Org: User:
Start: 07/31/10 End: 01/31/12 Due: 01/31/13

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control

Phase: N/A Priority: Normal
NCT ID: NCT02281318 Org: User:
Start: 12/11/14 End: 06/10/16 Due: 06/10/17

Cross-Over Study in Subjects With COPD, Evaluating Lung Function Response After Treatment With Once Daily Umeclidinium 62.5mcg, Vilanterol 25mcg, and Umeclidinium/Vilanterol 62.5/25mcg

Phase: N/A Priority: Normal
NCT ID: NCT01716520 Org: User:
Start: 10/31/12 End: 03/31/13 Due: 03/31/14

Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above

Phase: N/A Priority: Normal
NCT ID: NCT04886596 Org: User:
Start: 05/25/21 End: 05/31/24 Due: 05/31/25

Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women

Phase: N/A Priority: Normal
NCT ID: NCT00337818 Org: User:
Start: 06/30/06 End: 01/31/09 Due: 01/31/10

A Study To Assess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT00551772 Org: User:
Start: 08/31/07 End: - Due: -

Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01457560 Org: User:
Start: 02/29/00 End: 04/30/01 Due: 04/30/02

A Phase I Pharmacokinetic Study of Fluticasone Furoate /Umeclidinium Bromide/Vilanterol (100/62.5/25 Microgram [mcg]) After Single and Repeat Dose Administration From a Dry Powder Inhaler in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02837380 Org: User:
Start: 09/30/16 End: 11/30/16 Due: 11/30/17

Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02105961 Org: User:
Start: 04/24/14 End: 01/16/17 Due: 01/16/18

A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State

Phase: N/A Priority: Normal
NCT ID: NCT00537654 Org: User:
Start: 10/18/07 End: 02/22/08 Due: 02/22/09

Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil)

Phase: N/A Priority: Normal
NCT ID: NCT01376232 Org: User:
Start: 11/08/10 End: 12/20/10 Due: 12/20/11

Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine.

Phase: N/A Priority: Normal
NCT ID: NCT00420316 Org: User:
Start: 02/12/07 End: 08/08/07 Due: 08/08/08

Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children

Phase: N/A Priority: Normal
NCT ID: NCT01196988 Org: User:
Start: 10/04/10 End: 06/15/11 Due: 06/15/12

ARTS - AVODART After Radical Therapy For Prostate Cancer Study

Phase: N/A Priority: Normal
NCT ID: NCT00558363 Org: User:
Start: 11/30/07 End: 03/31/11 Due: 03/31/12

Vaccine Efficacy Against Rotavirus Diarrhea; Vaccine Given With Routine Childhood Vaccinations in Healthy African Infants

Phase: N/A Priority: Normal
NCT ID: NCT00241644 Org: User:
Start: 10/31/05 End: 06/30/08 Due: 06/30/09

GSK1349572 Drug Interaction Study With Etravirine

Phase: N/A Priority: Normal
NCT ID: NCT00774111 Org: User:
Start: 10/31/08 End: 12/31/08 Due: 12/31/09

Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules

Phase: N/A Priority: Normal
NCT ID: NCT00697229 Org: User:
Start: 09/30/92 End: 12/31/98 Due: 12/31/99

A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics

Phase: N/A Priority: Normal
NCT ID: NCT01119846 Org: User:
Start: 06/05/09 End: 03/19/10 Due: 03/19/11